InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-1.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pavliv Leo, Vice-Président Senior et Directeur du Développement. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Aggregated, 3 disclosures have been published. History available since 17 March 2021. The latest transaction was filed on 31 May 2022 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
33,500 shares@ US$2.090.080% mcap80.8% of flowCommon StockSEC:0001209191-22-040113:0
2,870 shares@ US$3.220.0095% mcap9.6% of flowCommon StockSEC:0001209191-21-039925:0
2,870 shares@ US$3.229.6% of flowCommon StockSEC:0001209191-21-039925
3 of 3 declarations
About Pavliv Leo
Leo Pavliv is Senior Vice President and Chief Development Officer at Cumberland Pharmaceuticals Inc. He oversees the company's strategic development and growth initiatives, playing a key role in optimizing operations and products.
